Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis

BACKGROUND: Continuous use of glucocorticoids (GCs) has become the primary cause of secondary osteoporosis. Bisphosphonate drugs were given priority over denosumab and teriparatide in the 2017 American College of Rheumatology (ACR) guidelines but have a series of shortcomings. This study aims to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Chuanjian, Liang, Yanchen, Zhu, Kai, Xie, Wenpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286508/
https://www.ncbi.nlm.nih.gov/pubmed/37349750
http://dx.doi.org/10.1186/s13018-023-03920-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286508/
https://www.ncbi.nlm.nih.gov/pubmed/37349750
http://dx.doi.org/10.1186/s13018-023-03920-4

Ejemplares similares